ヘルスケアコンサルティングサービスの世界市場：サービスタイプ別、エンドユーザー別、地域別 - 予測（～2030年）

世界のヘルスケアコンサルティングサービスの市場規模は、2025年の321億7,000万米ドルから2030年までに519億5,000万米ドルに達すると予測され、予測期間にCAGRで10.1%の成長が見込まれます。

電子カルテ、遠隔医療、AIを活用した診断の採用への需要の高まりに加え、バリューベースケアへのシフトと運用コストの圧力が、専門家によるアドバイザリーサービスへの需要を促進しています。さらに、新興市場における医療インフラの拡大や、製薬とMedTech（メドテック）におけるイノベーションが市場成長を後押ししています。

サービスタイプ別では、IT・デジタルトランスフォーメーションコンサルティングサービスセグメントが予測期間に市場を独占する見込みです。

サービスタイプ別では、ヘルスケアコンサルティングサービス市場は、IT・デジタルトランスフォーメーションコンサルティングサービス、戦略コンサルティングサービス、経営コンサルティングサービス、財務コンサルティングサービス、HR・人材コンサルティングサービス、マーケティング・セールス・商業化コンサルティングサービス、規制遵守、研究開発コンサルティングサービス、公衆衛生コンサルティングサービス、その他のサービスに区分されます。IT・デジタルトランスフォーメーション・コンサルティングサービス部門の成長率がもっとも高いのは、電子カルテ（EHR）と遠隔医療プラットフォームの採用の進行や、診断と業務におけるAIの活用、クラウドコンピューティングの重要性、サイバーセキュリティソリューションの進歩によるものです。

エンドユーザー別では、製薬・バイオテクノロジー企業が2024年に最大の市場シェアを占めました。

ヘルスケアコンサルティングサービス市場は、エンドユーザーによって政府機関、医療提供者、医療保険者、製薬・バイオテクノロジー企業、医療機器企業、その他のエンドユーザーに区分されます。2024年、製薬・バイオテクノロジー企業が最大の市場シェアを占めました。この優位性は、API業務、製剤開発、サプライチェーン管理におけるコスト最適化へのニーズの高まりによるものです。これらの企業はまた、複雑かつ変更頻度の高い規制要件に直面しており、コンプライアンス、M&A、製品上市戦略、ブランド管理に関する専門家の指導を必要としています。

地域別では、北米が2024年に最大の市場シェアを占めました。

世界のヘルスケアコンサルティングサービス市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカに区分されます。2024年、北米が最大の市場シェアを占めました。このセグメントの大きなシェアは、高度に発達した医療インフラ、多額の医療費、デジタルヘルス技術の広範な採用、強力な規制枠組みに起因します。主要ヘルスケアコンサルティング企業のプレゼンスや、先進の保険者・提供者モデル、そしてバリューベースケア、AI、患者体験への継続的な投資が、この部門における北米のリーダーシップをさらに強化しています。

当レポートでは、世界のヘルスケアコンサルティングサービス市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要な知見

• ヘルスケアコンサルティングサービス市場の概要
• アジア太平洋のヘルスケアコンサルティングサービス市場：国別、エンドユーザー別
• ヘルスケアコンサルティングサービス市場：地域の成長機会
• ヘルスケアコンサルティングサービス市場：地域構成
• ヘルスケアコンサルティングサービス市場：新興市場と先進市場

第5章 市場の概要

• イントロダクション
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
• 産業動向
  • 医療におけるデジタルトランスフォーメーション
  • バリューベースケアへの移行
  • 患者中心のケアへの注目
  • 健康の社会的決定要因の重要性の高まり
  • データアナリティクスの使用の拡大
  • 精密医療の成長
• 顧客ビジネスに影響を与える動向/混乱
• 参考価格分析
  • 参考価格分析：サービス種別
  • 参考価格分析：地域別
• バリューチェーン分析
• エコシステム分析
• 投資と資金調達のシナリオ
• 技術分析
  • 主要技術
  • 補完技術
  • 隣接技術
• 主な会議とイベント（2025年～2026年）
• ケーススタディ分析
  • ペーパーレスプロセスによる患者体験の向上
  • 人材管理能力を向上させる先進のクラウドソリューション
  • 効果的な治療に向けたリスク管理計画の開発
• 規制情勢
  • 規制機関、政府機関、その他の組織
  • 規制分析
• ポーターのファイブフォース分析
• 主なステークホルダーと購入基準
• ビジネスモデル
• 2025年の米国関税の影響
  • イントロダクション
  • 主な関税率
  • 価格の影響の分析
  • 国/地域に対する影響
  • 最終用途産業に対する影響

第6章 ヘルスケアコンサルティングサービス市場：サービスタイプ別

• イントロダクション
• IT/デジタルトランスフォーメーションコンサルティング
• 戦略コンサルティング
• 経営コンサルティング
• 財務コンサルティング
• HR・人材コンサルティング
• マーケティング・セールス・商業化コンサルティング
• 規制遵守
• 研究開発コンサルティング
• 公衆衛生コンサルティング
• その他のコンサルティングサービス

第7章 ヘルスケアコンサルティングサービス市場：エンドユーザー別

• イントロダクション
• 政府機関
• 医療提供者
  • 病院
  • 外来診療センター
  • 長期ケア施設
  • 診断・画像診断センター
  • その他の医療提供者
• 健康保険者
  • 民間保険者
  • 公的保険者
• 製薬・バイオテクノロジー企業
• 医療機器企業
• その他のエンドユーザー

第8章 ヘルスケアコンサルティングサービス市場：地域別

• イントロダクション
• 北米
  • 北米のマクロ経済の見通し
  • 米国
  • カナダ
• 欧州
  • 欧州のマクロ経済の見通し
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • アジア太平洋のマクロ経済の見通し
  • 日本
  • 中国
  • インド
  • その他のアジア太平洋
• ラテンアメリカ
  • ラテンアメリカのマクロ経済の見通し
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
• 中東・アフリカ
  • 中東・アフリカのマクロ経済の見通し
  • GCC諸国
  • その他の中東・アフリカ

第9章 競合情勢

• 概要
• 主要参入企業の戦略/強み
• 収益分析（2020年～2024年）
• 市場シェア分析（2024年）
• 企業の評価と財務指標
• ブランド/ソフトウェアの比較
• 企業の評価マトリクス：主要企業（2024年）
• 企業の評価マトリクス：スタートアップ/中小企業（2024年）
• 競合シナリオ

第10章 企業の概要

• 主要企業
  • ACCENTURE
  • COGNIZANT
  • DELOITTE
  • MCKINSEY & COMPANY
  • BOSTON CONSULTING GROUP
  • PWC
  • EY
  • HURON CONSULTING GROUP INC.
  • KPMG
  • BAIN & COMPANY, INC.
  • IQVIA INC.
  • L.E.K. CONSULTING
  • NTT DATA, INC.
  • OLIVER WYMAN, LLC
  • SIMON-KUCHER & PARTNERS
  • IBM
  • CLEARVIEW HEALTHCARE PARTNERS
  • ALVAREZ & MARSAL HOLDINGS, LLC
  • ZS ASSOCIATES
  • CHARTIS
• その他の企業
  • QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED
  • LUCID HEALTH CONSULTING
  • BLUE MATTER CONSULTING
  • ISOS CONSULTANCY SERVICES PVT. LTD.
  • BACK BAY LIFE SCIENCE ADVISORS

第11章 付録

List of Tables

• TABLE 1 HEALTHCARE CONSULTING SERVICES MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021-2024
• TABLE 3 FACTOR ANALYSIS
• TABLE 4 HEALTHCARE CONSULTING SERVICES MARKET: RISK ANALYSIS
• TABLE 5 HEALTHCARE CONSULTING SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 6 INDICATIVE PRICING ANALYSIS FOR HEALTHCARE CONSULTING SERVICES, BY TYPE, 2024
• TABLE 7 HEALTHCARE CONSULTING SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 8 HEALTHCARE CONSULTING SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 HEALTHCARE CONSULTING SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
• TABLE 16 KEY BUYING CRITERIA FOR TOP THREE END USERS
• TABLE 17 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 18 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 19 KEY PLAYERS PROVIDING IT/DIGITAL TRANSFORMATION CONSULTING SERVICES
• TABLE 20 IT/DIGITAL TRANSFORMATION CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 21 KEY PLAYERS PROVIDING STRATEGY CONSULTING SERVICES
• TABLE 22 STRATEGY CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 23 KEY PLAYERS PROVIDING OPERATIONS CONSULTING SERVICES
• TABLE 24 OPERATIONS CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 25 KEY PLAYERS PROVIDING FINANCIAL CONSULTING SERVICES
• TABLE 26 FINANCIAL CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 27 KEY PLAYERS PROVIDING HR & TALENT CONSULTING SERVICES
• TABLE 28 HR & TALENT CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 29 KEY PLAYERS PROVIDING MARKETING, SALES, AND COMMERCIALIZATION CONSULTING SERVICES
• TABLE 30 MARKETING, SALES & COMMERCIALIZATION CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 31 KEY PLAYERS PROVIDING REGULATORY & COMPLIANCE CONSULTING SERVICES
• TABLE 32 REGULATORY & COMPLIANCE CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 33 KEY PLAYERS PROVIDING R&D CONSULTING SERVICES
• TABLE 34 R&D CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 35 KEY PLAYERS PROVIDING PUBLIC HEALTH CONSULTING SERVICES
• TABLE 36 PUBLIC HEALTH CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 37 KEY PLAYERS PROVIDING OTHER CONSULTING SERVICES
• TABLE 38 OTHER CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 39 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 40 HEALTHCARE CONSULTING SERVICES MARKET FOR GOVERNMENT BODIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 41 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 42 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 43 HEALTHCARE CONSULTING SERVICES MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 44 HEALTHCARE CONSULTING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 45 HEALTHCARE CONSULTING SERVICES MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 HEALTHCARE CONSULTING SERVICES MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 47 HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 48 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 49 HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 50 HEALTHCARE CONSULTING SERVICES MARKET FOR PRIVATE PAYERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 51 HEALTHCARE CONSULTING SERVICES MARKET FOR PUBLIC PAYERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 52 HEALTHCARE CONSULTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 53 HEALTHCARE CONSULTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 54 HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 55 HEALTHCARE CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 58 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 59 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 60 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 61 US: KEY MACROECONOMIC INDICATORS
• TABLE 62 US: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 63 US: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 64 US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 65 US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 66 CANADA: KEY MACROECONOMIC INDICATORS
• TABLE 67 CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 68 CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 69 CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 70 CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 71 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 72 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 73 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 74 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 75 EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 76 GERMANY: KEY MACROECONOMIC INDICATORS
• TABLE 77 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 78 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 79 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 80 GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 81 UK: KEY MACROECONOMIC INDICATORS
• TABLE 82 UK: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 83 UK: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 84 UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 85 UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 86 FRANCE: KEY MACROECONOMIC INDICATORS
• TABLE 87 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 88 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 89 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 90 FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 91 ITALY: KEY MACROECONOMIC INDICATORS
• TABLE 92 ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 93 ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 94 ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 95 ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 96 SPAIN: KEY MACROECONOMIC INDICATORS
• TABLE 97 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 98 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 99 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 100 SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 101 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 102 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 103 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 104 REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 105 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 106 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 107 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 108 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 109 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 110 JAPAN: KEY MACROECONOMIC INDICATORS
• TABLE 111 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 112 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 113 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 114 JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 115 CHINA: KEY MACROECONOMIC INDICATORS
• TABLE 116 CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 117 CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 118 CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 119 CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 120 INDIA: KEY MACROECONOMIC INDICATORS
• TABLE 121 INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 122 INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 123 INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 124 INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 125 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 126 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 127 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 128 REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 129 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 131 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 132 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 133 LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 134 BRAZIL: KEY MACROECONOMIC INDICATORS
• TABLE 135 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 136 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 137 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 138 BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 139 MEXICO: KEY MACROECONOMIC INDICATORS
• TABLE 140 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 141 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 142 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 143 MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 144 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 145 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 146 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 147 REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 148 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 149 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 150 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 151 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 152 MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 153 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 154 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 155 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 156 GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 157 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023-2030 (USD MILLION)
• TABLE 158 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 159 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 160 REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023-2030 (USD MILLION)
• TABLE 161 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, JANUARY 2022-MAY 2025
• TABLE 162 HEALTHCARE CONSULTING SERVICES MARKET: DEGREE OF COMPETITION
• TABLE 163 HEALTHCARE CONSULTING SERVICES MARKET: REGION FOOTPRINT, 2024
• TABLE 164 HEALTHCARE CONSULTING SERVICES MARKET: TYPE OF SERVICE FOOTPRINT, 2024
• TABLE 165 HEALTHCARE CONSULTING SERVICES MARKET: END-USER FOOTPRINT, 2024
• TABLE 166 HEALTHCARE CONSULTING SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 167 HEALTHCARE CONSULTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 168 HEALTHCARE CONSULTING SERVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 169 HEALTHCARE CONSULTING SERVICES MARKET: DEALS, JANUARY 2022-MAY 2025
• TABLE 170 HEALTHCARE CONSULTING SERVICES MARKET: EXPANSIONS, JANUARY 2022-MAY 2025
• TABLE 171 HEALTHCARE CONSULTING SERVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
• TABLE 172 ACCENTURE: COMPANY OVERVIEW
• TABLE 173 ACCENTURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 174 ACCENTURE: DEALS, JANUARY 2022-MAY 2025
• TABLE 175 COGNIZANT: COMPANY OVERVIEW
• TABLE 176 COGNIZANT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 177 COGNIZANT: DEALS, JANUARY 2022-MAY 2025
• TABLE 178 COGNIZANT: EXPANSIONS, JANUARY 2022-MAY 2025
• TABLE 179 DELOITTE: COMPANY OVERVIEW
• TABLE 180 DELOITTE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 181 DELOITTE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 182 DELOITTE: DEALS, JANUARY 2022-MAY 2025
• TABLE 183 MCKINSEY & COMPANY: COMPANY OVERVIEW
• TABLE 184 MCKINSEY & COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 185 MCKINSEY & COMPANY: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 186 MCKINSEY & COMPANY: DEALS, JANUARY 2022-MAY 2025
• TABLE 187 BOSTON CONSULTING GROUP: COMPANY OVERVIEW
• TABLE 188 BOSTON CONSULTING GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 189 BOSTON CONSULTING GROUP: DEALS, JANUARY 2022- MAY 2025
• TABLE 190 PWC: COMPANY OVERVIEW
• TABLE 191 PWC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 192 PWC: DEALS, JANUARY 2022-MAY 2025
• TABLE 193 EY: COMPANY OVERVIEW
• TABLE 194 EY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 195 EY: PRODUCT LAUNCHES, JANUARY 2022- MAY 2025
• TABLE 196 HURON CONSULTING GROUP INC.: COMPANY OVERVIEW
• TABLE 197 HURON CONSULTING GROUP INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 198 HURON CONSULTING GROUP INC.: DEALS, JANUARY 2022- MAY 2025
• TABLE 199 KPMG: COMPANY OVERVIEW
• TABLE 200 KPMG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 201 KPMG: PRODUCT LAUNCHES, JANUARY 2022- MAY 2025
• TABLE 202 KPMG: DEALS, JANUARY 2022- MAY 2025
• TABLE 203 BAIN & COMPANY, INC.: COMPANY OVERVIEW
• TABLE 204 BAIN & COMPANY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 205 BAIN & COMPANY, INC.: DEALS, JANUARY 2022- MAY 2025
• TABLE 206 IQVIA INC.: COMPANY OVERVIEW
• TABLE 207 IQVIA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 208 IQVIA, INC.: PRODUCT LAUNCHES, JANUARY 2022- MAY 2025
• TABLE 209 IQVIA, INC.: DEALS, JANUARY 2022- MAY 2025
• TABLE 210 L.E.K CONSULTING: COMPANY OVERVIEW
• TABLE 211 L.E.K CONSULTING: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 212 L.E.K. CONSULTING: DEALS, JANUARY 2022-MAY 2025
• TABLE 213 L.E.K CONSULTING: EXPANSIONS, JANUARY 2022-MAY 2025
• TABLE 214 NTT DATA, INC.: COMPANY OVERVIEW
• TABLE 215 NTT DATA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 216 NTT DATA, INC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 217 NTT DATA, INC.: DEALS, JANUARY 2022-MAY 2025
• TABLE 218 OLIVER WYMAN, LLC: COMPANY OVERVIEW
• TABLE 219 OLIVER WYMAN, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 220 OLIVER WYMAN, LLC: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 221 OLIVER WYMAN, LLC: DEALS, JANUARY 2022-MAY 2025
• TABLE 222 SIMON-KUCHER & PARTNERS: COMPANY OVERVIEW
• TABLE 223 SIMON-KUCHER & PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 224 IBM: COMPANY OVERVIEW
• TABLE 225 IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 226 IBM: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 227 IBM: DEALS, JANUARY 2022-MAY 2025
• TABLE 228 CLEARVIEW HEALTHCARE PARTNERS: COMPANY OVERVIEW
• TABLE 229 CLEARVIEW HEALTHCARE PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 230 CLEARVIEW HEALTHCARE PARTNER: OTHER DEALS, JANUARY 2022-MAY 2025
• TABLE 231 ALVAREZ & MARSAL HOLDINGS, LLC: COMPANY OVERVIEW
• TABLE 232 ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCTS OFFERED
• TABLE 233 ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCT LAUNCHES, JANUARY 2022-MAY 2024
• TABLE 234 ZS ASSOCIATES: COMPANY OVERVIEW
• TABLE 235 ZS ASSOCIATES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 236 ZS ASSOCIATES: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
• TABLE 237 ZS ASSOCIATES: DEALS, JANUARY 2022-MAY 2025
• TABLE 238 CHARTIS: COMPANY OVERVIEW
• TABLE 239 CHARTIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• TABLE 240 CHARTIS: DEALS, JANUARY 2022-MAY 2025
• TABLE 241 QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED: COMPANY OVERVIEW
• TABLE 242 LUCID HEALTH CONSULTING: COMPANY OVERVIEW
• TABLE 243 BLUE MATTER CONSULTING: COMPANY OVERVIEW
• TABLE 244 ISOS CONSULTANCY SERVICES PVT. LTD.: COMPANY OVERVIEW
• TABLE 245 BACK BAY LIFE SCIENCE ADVISORS: COMPANY OVERVIEW

List of Figures

• FIGURE 1 HEALTHCARE CONSULTING SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 PRIMARY SOURCES
• FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION
• FIGURE 8 HEALTHCARE CONSULTING SERVICES MARKET: REVENUE ESTIMATION APPROACH
• FIGURE 9 BOTTOM-UP APPROACH: COLLECTIVE REVENUE OF ALL SERVICES/SOLUTIONS OF VENDORS
• FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024-2030
• FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 12 TOP-DOWN APPROACH
• FIGURE 13 DATA TRIANGULATION METHODOLOGY
• FIGURE 14 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2025 VS. 2030 (USD MILLION)
• FIGURE 15 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 GEOGRAPHIC SNAPSHOT OF HEALTHCARE CONSULTING SERVICES MARKET
• FIGURE 17 GROWING ADOPTION OF HEALTHCARE IT SOLUTIONS TO DRIVE MARKET
• FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024
• FIGURE 19 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 20 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
• FIGURE 22 HEALTHCARE CONSULTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 23 MEDIAN HEALTHCARE DATA BREACH IN US, 2009-2024
• FIGURE 24 NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET
• FIGURE 25 HEALTHCARE CONSULTING SERVICES MARKET: VALUE CHAIN ANALYSIS
• FIGURE 26 HEALTHCARE CONSULTING SERVICES MARKET: ECOSYSTEM ANALYSIS
• FIGURE 27 INVESTMENT AND FUNDING SCENARIO, 2019-2024
• FIGURE 28 HEALTHCARE CONSULTING SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
• FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS
• FIGURE 31 NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT
• FIGURE 32 ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT
• FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, 2020-2024 (USD MILLION)
• FIGURE 34 HEALTHCARE CONSULTING SERVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
• FIGURE 35 EV/EBITDA OF KEY VENDORS, 2024
• FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE CONSULTING SERVICES VENDORS, 2024
• FIGURE 37 HEALTHCARE CONSULTING SERVICES MARKET: BRAND/SOFTWARE COMPARISON
• FIGURE 38 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 39 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY FOOTPRINT (KEY PLAYERS), 2024
• FIGURE 40 HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 41 ACCENTURE: COMPANY SNAPSHOT (2024)
• FIGURE 42 COGNIZANT: COMPANY SNAPSHOT (2024)
• FIGURE 43 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2024)
• FIGURE 44 KPMG: COMPANY SNAPSHOT (2024)
• FIGURE 45 IQVIA, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 46 NTT DATA, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 47 IBM: COMPANY SNAPSHOT (2024)

The healthcare consulting services market is projected to reach USD 51.95 billion by 2030 from USD 32.17 billion in 2025, at a CAGR of 10.1% during the forecast period. The growing demand for adopting electronic health records, telehealth, and AI-driven diagnostics, along with the shift toward value-based care and operational cost pressures, is driving demand for expert advisory services. Additionally, expanding healthcare infrastructure in emerging markets and innovation in pharma and MedTech fuel market growth.

By service type, the IT & digital transformation consulting services segment is expected to dominate the market during the forecast period.

By service type, the healthcare consulting services market is segmented into IT & digital transformation consulting services; strategy consulting services; operation consulting services; financial consulting services; HR & talent consulting services; marketing, sales, and commercialization consulting services; regulatory & compliance; R&D consulting services; public health consulting services; and other services. The highest growth rate of the IT & digital transformation consulting services segment is attributed to the increasing adoption of electronic health records (EHRs) and telemedicine platforms; the utilization of AI for diagnostics & operations; the importance of cloud computing; and the advancement of cybersecurity solutions.

By end user, the pharmaceutical & biotechnology companies segment accounted for the largest market share in 2024.

The healthcare consulting services market is segmented by end users into government bodies, healthcare providers, health insurance payers, pharmaceutical & biotechnological companies, medical device companies, and other end users. The pharmaceutical & biotechnological companies segment accounted for the largest market share in 2024. This dominance is driven by their growing need for cost optimization in API operations, formulation development, and supply chain management. These companies also face complex and frequently changing regulatory requirements, necessitating expert guidance on compliance, mergers and acquisitions, product launch strategies, and brand management.

By region, North America accounted for the largest market share in 2024.

The global healthcare consulting services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest market share. The large share of this segment is attributed to the highly developed healthcare infrastructure, substantial healthcare spending, widespread adoption of digital health technologies, and strong regulatory frameworks. The presence of leading healthcare consulting firms, advanced payer-provider models, and continuous investment in value-based care, AI, and patient experience further reinforces North America's leadership in the sector.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)
• By Designation - C-level Executives (31%), Director-level (25%), and Managers (44%)
• By Region - North America (45%), Europe (28%), the Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)

Key Players

The prominent players in this market are Accenture Plc (Ireland), Cognizant Technology Solutions Corporation (US), Deloitte (UK), McKinsey & Company (UK), PwC (UK), Ernst & Young Global Limited (EY) (UK), Huron Consulting Group Inc. (US), and KPMG (UK), among others.

Research Coverage

• The report studies the healthcare consulting services market based on service type, end user, and region.
• The report analyzes factors (drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the market's opportunities and challenges for stakeholders and details the competitive landscape for market leaders.
• The report studies micro-markets regarding their growth trends, prospects, and contributions to the total healthcare consulting services market.
• The report forecasts the revenue of market segments in five regions.

Reasons to Buy the Report

The report can help established and new entrants/smaller firms gauge the market's pulse, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers (Growing rate of digitization in healthcare, Increasing adoption of big data analytics, IoT, and cloud deployment in the healthcare industry, changing healthcare landscape with respect to regulatory compliance and technological evolution, decreasing number of in-house experts in the end-use industries, rising level of government support for HCIT solutions, growing need for structural changes and new business models in the healthcare industry, increasing number of patients suffering from various chronic and infectious diseases, and increasing pressure to reduce the rising healthcare costs), restraints (rising number of concerns regarding data confidentiality, increasing number of hidden costs of consulting services), opportunities (growing demand for cloud consulting, increasing potential for healthcare consulting services in the emerging markets, increasing consolidation in the healthcare industry), and challenges (rising number of multi-sourcing approaches, high cost of consulting services) influencing the growth of the healthcare consulting services market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare consulting services market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various healthcare consulting services solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Healthcare consulting services market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare consulting services market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS
  • 2.2.2 BOTTOM-UP APPROACH
  • 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.4 GROWTH FORECAST
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 PARAMETRIC ASSUMPTIONS
  • 2.4.2 STUDY-RELATED ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEALTHCARE CONSULTING SERVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY AND END USER
• 4.3 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
• 4.4 HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL MIX
• 4.5 HEALTHCARE CONSULTING SERVICES MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing trend of digitization
    • 5.2.1.2 Increasing adoption of big data analytics, IoT, and cloud deployment
    • 5.2.1.3 Changing healthcare landscape
    • 5.2.1.4 Rising government support for HCIT solutions
    • 5.2.1.5 Emergence of new business models
    • 5.2.1.6 Growing incidence of chronic and infectious diseases
    • 5.2.1.7 Need for data security
    • 5.2.1.8 Increasing pressure to reduce healthcare costs
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Data confidentiality concerns
    • 5.2.2.2 Hidden costs of consulting services
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising trend of consolidation
    • 5.2.3.2 Opportunities in emerging markets
    • 5.2.3.3 Consistent rise in mergers and acquisitions
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Rising number of multi-sourcing approaches
• 5.3 INDUSTRY TRENDS
  • 5.3.1 DIGITAL TRANSFORMATION IN HEALTHCARE
  • 5.3.2 SHIFT TOWARD VALUE-BASED CARE
  • 5.3.3 FOCUS ON PATIENT-CENTRIC CARE
  • 5.3.4 RISING IMPORTANCE OF SOCIAL DETERMINANTS OF HEALTH
  • 5.3.5 EXPANDING USE OF DATA ANALYTICS
  • 5.3.6 GROWTH OF PRECISION MEDICINE
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.5 INDICATIVE PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING ANALYSIS, BY TYPE OF SERVICE
  • 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Machine learning
    • 5.9.1.2 Artificial intelligence
    • 5.9.1.3 Cloud computing
    • 5.9.1.4 Big data and advanced analytics
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Robotic Process Automation (RPA)
    • 5.9.2.2 Natural Language Processing (NLP)
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Blockchain
    • 5.9.3.2 Internet of Things (IoT)
• 5.10 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 ENHANCED PATIENT EXPERIENCE WITH PAPERLESS PROCESS
  • 5.11.2 ADVANCED CLOUD SOLUTION TO IMPROVE HUMAN CAPITAL MANAGEMENT CAPABILITIES
  • 5.11.3 DEVELOPMENT OF RISK MANAGEMENT PLANS FOR EFFECTIVE TREATMENT
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12.2 REGULATORY ANALYSIS
    • 5.12.2.1 North America
    • 5.12.2.2 Europe
    • 5.12.2.3 Asia Pacific
    • 5.12.2.4 Middle East & Africa
    • 5.12.2.5 Latin America
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 BARGAINING POWER OF SUPPLIERS
  • 5.13.2 BARGAINING POWER OF BUYERS
  • 5.13.3 THREAT OF NEW ENTRANTS
  • 5.13.4 THREAT OF SUBSTITUTES
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 BUSINESS MODELS
• 5.16 IMPACT OF 2025 US TARIFF
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 IMPACT ON COUNTRY/REGION
    • 5.16.4.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 Asia Pacific
  • 5.16.5 IMPACT ON END-USE INDUSTRIES

6 HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE

• 6.1 INTRODUCTION
• 6.2 IT/DIGITAL TRANSFORMATION CONSULTING
  • 6.2.1 RISING DEMAND FOR MODERNIZATION AND VALUE-BASED CARE DELIVERY TO AID GROWTH
• 6.3 STRATEGY CONSULTING
  • 6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS TO FACILITATE GROWTH
• 6.4 OPERATIONS CONSULTING
  • 6.4.1 TRANSITION FROM FEE-FOR-SERVICE TO COORDINATED CARE MODEL TO SUSTAIN GROWTH
• 6.5 FINANCIAL CONSULTING
  • 6.5.1 RISING NEED FOR OPTIMIZED REVENUE CYCLE MANAGEMENT TO STIMULATE GROWTH
• 6.6 HR & TALENT CONSULTING
  • 6.6.1 ONGOING SHORTAGE OF HEALTHCARE PROFESSIONALS TO PROMOTE GROWTH
• 6.7 MARKETING, SALES, AND COMMERCIALIZATION CONSULTING
  • 6.7.1 INNOVATIONS IN DRUG DEVELOPMENT AND MEDICAL TECHNOLOGY TO DRIVE MARKET
• 6.8 REGULATORY & COMPLIANCE
  • 6.8.1 RAPID ADOPTION OF DIGITAL HEALTH TECHNOLOGIES TO AUGMENT GROWTH
• 6.9 R&D CONSULTING
  • 6.9.1 GROWING DEMAND FOR NEW DRUGS TO BOOST MARKET
• 6.10 PUBLIC HEALTH CONSULTING
  • 6.10.1 INCREASING INVESTMENTS IN PUBLIC HEALTH INFRASTRUCTURE TO FOSTER GROWTH
• 6.11 OTHER CONSULTING SERVICES

7 HEALTHCARE CONSULTING SERVICES MARKET, BY END USER

• 7.1 INTRODUCTION
• 7.2 GOVERNMENT BODIES
  • 7.2.1 GROWING INVESTMENTS IN MODERNIZING DIGITAL AND TECHNOLOGY INFRASTRUCTURE TO FUEL MARKET
• 7.3 HEALTHCARE PROVIDERS
  • 7.3.1 HOSPITALS
    • 7.3.1.1 Growing need for telehealth and remote care to propel market
  • 7.3.2 AMBULATORY CARE CENTERS
    • 7.3.2.1 Rising demand for convenient and patient-centered services to bolster growth
  • 7.3.3 LONG-TERM CARE FACILITIES
    • 7.3.3.1 Booming geriatric population to contribute to growth
  • 7.3.4 DIAGNOSTIC & IMAGING CENTERS
    • 7.3.4.1 Rising global demand for early disease detection, precision diagnostics, and outpatient imaging services to favor growth
  • 7.3.5 OTHER HEALTHCARE PROVIDERS
• 7.4 HEALTH INSURANCE PAYERS
  • 7.4.1 PRIVATE PAYERS
    • 7.4.1.1 Need for regulatory compliance to encourage growth
  • 7.4.2 PUBLIC PAYERS
    • 7.4.2.1 Growing digital transformation initiatives to boost market
• 7.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.5.1 EVOLVING LIFE SCIENCES LANDSCAPE TO SPUR GROWTH
• 7.6 MEDICAL DEVICE COMPANIES
  • 7.6.1 GROWING FOCUS OF MEDICAL DEVICE COMPANIES ON CUTTING-EDGE TECHNOLOGY TO DRIVE MARKET
• 7.7 OTHER END USERS

8 HEALTHCARE CONSULTING SERVICES MARKET, BY REGION

• 8.1 INTRODUCTION
• 8.2 NORTH AMERICA
  • 8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 8.2.2 US
    • 8.2.2.1 Advanced infrastructure and high healthcare spending to augment growth
  • 8.2.3 CANADA
    • 8.2.3.1 Shift toward technology-driven integrated healthcare model to spur growth
• 8.3 EUROPE
  • 8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 8.3.2 GERMANY
    • 8.3.2.1 Increasing emphasis on electronic documentation and compliance to spur growth
  • 8.3.3 UK
    • 8.3.3.1 Need for sectoral restructuring to accelerate growth
  • 8.3.4 FRANCE
    • 8.3.4.1 Need to ensure interoperability and compatibility among healthcare IT systems to aid growth
  • 8.3.5 ITALY
    • 8.3.5.1 Expansion of digital health sector to support growth
  • 8.3.6 SPAIN
    • 8.3.6.1 Growing digitization of healthcare systems to boost market
  • 8.3.7 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 8.4.2 JAPAN
    • 8.4.2.1 Increasing adoption of information technology in medical care and home nursing to promote growth
  • 8.4.3 CHINA
    • 8.4.3.1 Favorable government initiatives to bolster growth
  • 8.4.4 INDIA
    • 8.4.4.1 Growing adoption of connected healthcare ecosystem to boost market
  • 8.4.5 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 8.5.2 BRAZIL
    • 8.5.2.1 Ongoing efforts to modernize healthcare infrastructure to promote growth
  • 8.5.3 MEXICO
    • 8.5.3.1 Rising healthcare costs to contribute to growth
  • 8.5.4 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST & AFRICA
  • 8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 8.6.2 GCC COUNTRIES
    • 8.6.2.1 Increasing investments in healthcare infrastructure to contribute to growth
  • 8.6.3 REST OF MIDDLE EAST & AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET
• 9.3 REVENUE ANALYSIS, 2020-2024
• 9.4 MARKET SHARE ANALYSIS, 2024
• 9.5 COMPANY VALUATION AND FINANCIAL METRICS
• 9.6 BRAND/SOFTWARE COMPARISON
• 9.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 9.7.1 STARS
  • 9.7.2 EMERGING LEADERS
  • 9.7.3 PERVASIVE PLAYERS
  • 9.7.4 PARTICIPANTS
  • 9.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 9.7.5.1 Company footprint
    • 9.7.5.2 Region footprint
    • 9.7.5.3 Type of service footprint
    • 9.7.5.4 End-user footprint
• 9.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 9.8.1 PROGRESSIVE COMPANIES
  • 9.8.2 RESPONSIVE COMPANIES
  • 9.8.3 DYNAMIC COMPANIES
  • 9.8.4 STARTING BLOCKS
  • 9.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 9.8.5.1 Detailed list of key startups/SMEs
    • 9.8.5.2 Competitive benchmarking of key startups/SMEs
• 9.9 COMPETITIVE SCENARIO
  • 9.9.1 PRODUCT LAUNCHES
  • 9.9.2 DEALS
  • 9.9.3 EXPANSIONS
  • 9.9.4 OTHER DEVELOPMENTS

10 COMPLNY PROFILE

• 10.1 KEY PLAYERS
  • 10.1.1 ACCENTURE
    • 10.1.1.1 Business overview
    • 10.1.1.2 Products/Services/Solutions offered
    • 10.1.1.3 Recent developments
      • 10.1.1.3.1 Deals
    • 10.1.1.4 MnM view
      • 10.1.1.4.1 Key strengths
      • 10.1.1.4.2 Strategic choices
      • 10.1.1.4.3 Weaknesses and competitive threats
  • 10.1.2 COGNIZANT
    • 10.1.2.1 Business overview
    • 10.1.2.2 Products/Services/Solutions offered
    • 10.1.2.3 Recent developments
      • 10.1.2.3.1 Deals
      • 10.1.2.3.2 Expansions
    • 10.1.2.4 MnM view
      • 10.1.2.4.1 Key strengths
      • 10.1.2.4.2 Strategic choices
      • 10.1.2.4.3 Weaknesses and competitive threats
  • 10.1.3 DELOITTE
    • 10.1.3.1 Business overview
    • 10.1.3.2 Products/Services/Solutions offered
    • 10.1.3.3 Recent developments
      • 10.1.3.3.1 Product launches
      • 10.1.3.3.2 Deals
    • 10.1.3.4 MnM view
      • 10.1.3.4.1 Key strengths
      • 10.1.3.4.2 Strategic choices
      • 10.1.3.4.3 Weaknesses and competitive threats
  • 10.1.4 MCKINSEY & COMPANY
    • 10.1.4.1 Business overview
    • 10.1.4.2 Products/Services/Solutions offered
    • 10.1.4.3 Recent developments
      • 10.1.4.3.1 Product launches
    • 10.1.4.4 Recent developments
      • 10.1.4.4.1 Deals
    • 10.1.4.5 MnM view
      • 10.1.4.5.1 Key strengths
      • 10.1.4.5.2 Strategic choices
      • 10.1.4.5.3 Weaknesses and competitive threats
  • 10.1.5 BOSTON CONSULTING GROUP
    • 10.1.5.1 Business overview
    • 10.1.5.2 Products/Services/Solutions offered
    • 10.1.5.3 Recent developments
      • 10.1.5.3.1 Deals
    • 10.1.5.4 MnM view
      • 10.1.5.4.1 Key strengths
      • 10.1.5.4.2 Strategic choices
      • 10.1.5.4.3 Weaknesses and competitive threats
  • 10.1.6 PWC
    • 10.1.6.1 Business overview
    • 10.1.6.2 Products/Services/Solutions offered
    • 10.1.6.3 Recent developments
      • 10.1.6.3.1 Deals
  • 10.1.7 EY
    • 10.1.7.1 Business overview
    • 10.1.7.2 Products/Services/Solutions offered
    • 10.1.7.3 Recent developments
      • 10.1.7.3.1 Product launches
  • 10.1.8 HURON CONSULTING GROUP INC.
    • 10.1.8.1 Business overview
    • 10.1.8.2 Products/Services/Solutions offered
    • 10.1.8.3 Recent developments
      • 10.1.8.3.1 Deals
  • 10.1.9 KPMG
    • 10.1.9.1 Business overview
    • 10.1.9.2 Products/Services/Solutions offered
    • 10.1.9.3 Recent developments
      • 10.1.9.3.1 Product launches
      • 10.1.9.3.2 DEALS
  • 10.1.10 BAIN & COMPANY, INC.
    • 10.1.10.1 Business overview
    • 10.1.10.2 Products/Services/Solutions offered
    • 10.1.10.3 Recent developments
      • 10.1.10.3.1 Deals
  • 10.1.11 IQVIA INC.
    • 10.1.11.1 Business overview
    • 10.1.11.2 Products/Services/Solutions offered
    • 10.1.11.3 Recent developments
      • 10.1.11.3.1 Product launches
    • 10.1.11.4 Recent developments
      • 10.1.11.4.1 Deals
  • 10.1.12 L.E.K. CONSULTING
    • 10.1.12.1 Business overview
    • 10.1.12.2 Products/Services/Solutions offered
    • 10.1.12.3 Recent developments
      • 10.1.12.3.1 Deals
      • 10.1.12.3.2 Expansions
  • 10.1.13 NTT DATA, INC.
    • 10.1.13.1 Business overview
    • 10.1.13.2 Products/Services/Solutions offered
    • 10.1.13.3 Recent developments
      • 10.1.13.3.1 Product launches
      • 10.1.13.3.2 Deals
  • 10.1.14 OLIVER WYMAN, LLC
    • 10.1.14.1 Business overview
    • 10.1.14.2 Products/Services/Solutions offered
    • 10.1.14.3 Recent developments
      • 10.1.14.3.1 Product launches
      • 10.1.14.3.2 Deals
  • 10.1.15 SIMON-KUCHER & PARTNERS
    • 10.1.15.1 Business overview
    • 10.1.15.2 Products/Services/Solutions offered
  • 10.1.16 IBM
    • 10.1.16.1 Business overview
    • 10.1.16.2 Products/Services/Solutions offered
    • 10.1.16.3 Recent developments
      • 10.1.16.3.1 Product launches
      • 10.1.16.3.2 Deals
  • 10.1.17 CLEARVIEW HEALTHCARE PARTNERS
    • 10.1.17.1 Business overview
    • 10.1.17.2 Products/Services/Solutions offered
    • 10.1.17.3 Recent developments
      • 10.1.17.3.1 Other developments
  • 10.1.18 ALVAREZ & MARSAL HOLDINGS, LLC
    • 10.1.18.1 Business overview
    • 10.1.18.2 Products offered
    • 10.1.18.3 Recent developments
      • 10.1.18.3.1 Product launches
  • 10.1.19 ZS ASSOCIATES
    • 10.1.19.1 Business overview
    • 10.1.19.2 Products/Services/Solutions offered
    • 10.1.19.3 Recent developments
      • 10.1.19.3.1 Product launches
      • 10.1.19.3.2 Deals
  • 10.1.20 CHARTIS
    • 10.1.20.1 Business overview
    • 10.1.20.2 Products/Services/Solutions offered
    • 10.1.20.3 Recent developments
      • 10.1.20.3.1 Deals
• 10.2 OTHER PLAYERS
  • 10.2.1 QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED
  • 10.2.2 LUCID HEALTH CONSULTING
  • 10.2.3 BLUE MATTER CONSULTING
  • 10.2.4 ISOS CONSULTANCY SERVICES PVT. LTD.
  • 10.2.5 BACK BAY LIFE SCIENCE ADVISORS

11 APPENDIX

• 11.1 DISCUSSION GUIDE
• 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 11.3 CUSTOMIZATION OPTIONS
• 11.4 RELATED REPORTS
• 11.5 AUTHOR DETAILS